ArticleScientific reports2025
Gadoxetic acid-enhanced magnetic resonance imaging to predict pathologic complete response of colorectal liver metastases in preoperative chemotherapy.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- [Surgical treatment of metastatic liver cancer: the biological-behavioral basis of "homotherapy for heteropathy"].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026Review
- Immune microenvironment regulation and clinical immunotherapy strategies of metastatic liver cancer.Frontiers in immunology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent advances in chemotherapy have expanded the opportunity for curative resection of colorectal liver metastases (CRLMs). Disappearing liver metastases (DLMs) are often encountered following chemotherapy. This study aimed to determine whether the DLMs observed by contrast-enhanced computed tomography (CECT) and gadoxetic acid-enhanced magnetic resonance imaging (EOB-MRI) following preoperative chemotherapy were associated with a pathologic complete response(pCR). Patients who underwent hepatectomy between April 2020 and December 2022, following preoperative chemotherapy at our institution, were selected. Before chemotherapy, all patients underwent CECT, some patients also underwent EOB-MRI, and both imaging studies were performed on all patients after chemotherapy. Pathologic responses of all resected tumors were evaluated. For the unresected DLMs, they were defined as DLMs if they did not reappear in the imaging studies conducted over the following year. A total of 29 patients were selected. After chemotherapy, 138 DLMs were found by CECT and 106 were found by EOB-MRI. Of the resected DLMs confirmed only by CECT, tumor cells remained in 90% of them. All of resected DLMs confirmed by EOB-MRI showed a pCR. Of the remaining 39 unresected DLMs, one reappeared within a year. EOB-MRI is superior to CECT for the diagnosis of DLMs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.